Skip to main content
Caplight Logo









CANKADO GmbH

CANKADO GmbH

Private
MunichHealthcare & Life Scienceshttps://cankado.com/

Last Round

Financing Round

Jul 22, 2021

Company Overview

CANKADO GmbH is a digital health company that develops innovative digital therapeutics and patient support solutions for individuals with chronic conditions.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Patient Engagement, Vertical SaaS, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

electronic patient-reported outcomesePROelectronic clinical outcome assessmentseCOAremote patient monitoringdigital healthclinical trial softwarepatient support platformDiGAdigital health applicationpatient engagementeHealthclinical researchtelemedicinevertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CANKADO GmbH Comparables

Compare CANKADO GmbH with similar companies based on industry and business-model similarity.

CANKADO GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Climedo Health
88%
uMotif
84%
XO Life
81%

CANKADO GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Financing RoundJul 22, 2021
Series AOct 28, 2020
SeedDec 12, 2016

Key People

Founding team and executive leadership

Baiju R.

Co-Founder CTO Geschäftsführer

Founding Team

Ashir Ashraf

Chief Global Strategist at CANKADO, CEO CANKADO INDIA

Executive Team

Timo Schinköthe

CEO

Executive Team

CANKADO GmbH Investors

Notable investors and investment history

CANKADO GmbH investors
InvestorRounds
High-Tech GründerfondsSeries A, Seed
Business AngelSeed
Heal CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 39% MoM.

  • Jan 21, 2025

    Grew 17% QoQ, from 24 to 28 employees.

CANKADO GmbH Filings

Explore SEC and related filing metadata, where available.

CANKADO GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CANKADO GmbH's valuation, stock price, and market status.

Is CANKADO GmbH a public or private company?

CANKADO GmbH is a private company.

What is the current stock price of CANKADO GmbH?

CANKADO GmbH is a private company with no public stock price. Caplight tracks CANKADO GmbH's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is CANKADO GmbH worth (valuation)?

Valuation information for CANKADO GmbH is not publicly available.

Can I buy CANKADO GmbH stock?

CANKADO GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CANKADO GmbH's last funding round?

CANKADO GmbH's most recent funding round was Financing Round on July 22, 2021.

Who are the main investors in CANKADO GmbH?

Key investors in CANKADO GmbH include Heal Capital.

Will CANKADO GmbH IPO soon?

No public IPO plans have been announced for CANKADO GmbH.

How can I track CANKADO GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CANKADO GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMunich
Employee Range25
Year Founded2015
Last FundingJul 22, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?